日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study

节拍式化疗(mCHT)与标准化疗(sCHT)作为HR+/HER2-转移性乳腺癌(MBC)患者内分泌治疗失败后的一线治疗方案的比较。VICTOR-15匹配对照研究

Cazzaniga, Marina Elena; Galimberti, Stefania; Pepe, Francesca Fulvia; Cogliati, Viola; Sandretti, Francesco; Capici, Serena

Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.

晚期三阴性乳腺癌患者接受节拍式治疗后进行常规治疗,NOTCH-1 及其分子靶点的差异表达

Ilari Alice, Cogliati Viola, Sherif Noorhan, Grassilli Emanuela, Ramazzotti Daniele, Cordani Nicoletta, Cazzaniga Giorgio, Di Bella Camillo, Lavitrano Marialuisa, Cazzaniga Marina Elena, Cerrito Maria Grazia

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story

CDK4/6抑制剂治疗后HR+/HER2-转移性乳腺癌患者的治疗策略:一个未完待续的故事

Cogliati, Viola; Capici, Serena; Pepe, Francesca Fulvia; di Mauro, Pierluigi; Riva, Francesca; Cicchiello, Federica; Maggioni, Claudia; Cordani, Nicoletta; Cerrito, Maria Grazia; Cazzaniga, Marina Elena

Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows

节拍化疗治疗转移性乳腺癌:临床与临床前数据的亮点与不足

Cazzaniga, Marina Elena; Capici, Serena; Cordani, Nicoletta; Cogliati, Viola; Pepe, Francesca Fulvia; Riva, Francesca; Cerrito, Maria Grazia

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects

皮肤黑色素瘤的分子和免疫生物标志物:现状与展望

Pilla, Lorenzo; Alberti, Andrea; Di Mauro, Pierluigi; Gemelli, Maria; Cogliati, Viola; Cazzaniga, Marina Elena; Bidoli, Paolo; Maccalli, Cristina